Sign in

CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475617627
Phone
(617) 231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. 4 Grant or award Director acquired 138 shares (grant or award)
  2. 4 Grant or award Director acquired 461 shares (grant or award)
  3. 4 Grant or award Director acquired 222 shares (grant or award)
  4. 4 Grant or award Director acquired 194 shares (grant or award)
  5. 4 Open-market sale Chief Medical Officer sold 15,000 shares at an average $45.43 ($681,438)
  6. 4 Open-market sale Director sold 1,850 shares at an average $50.04 ($92,573)
  7. 4 Open-market sale Director sold 32,743 shares at an average $50.28 ($1,646,251)
  8. 4 Open-market sale Director sold 21,161 shares at an average $50.09 ($1,059,956)
  9. 4 Open-market sale Director sold 755 shares at $49.89 ($37,667)
  10. 4 Open-market sale Director sold 81,676 shares at an average $48.78 ($3,984,396)
  11. 4 Open-market sale Director sold 9,210 shares at an average $50.05 ($460,985)
  12. 4 Open-market sale Chief Legal Officer sold 12,500 shares at $50.00 ($625,000)
  13. 4 Open-market sale Director sold 755 shares at $40.73 ($30,751)
  14. 4 Grant or award Director acquired 157 shares (grant or award)
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations · Regulation FD disclosure
  17. 4 Open-market sale Director sold 14,407 shares at $45.16 ($650,587)
  18. 4 Open-market sale Chief Scientific Officer sold 17,057 shares at $45.01 ($767,812)
  19. 4 Open-market sale Chief Legal Officer sold 12,500 shares at $45.00 ($562,500)
  20. 4 Open-market sale Director sold 15,593 shares at an average $45.01 ($701,774)

Page 22 of 28 · 549 filings